Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bandim Health Project, Bissau
Female mortality increased when measles vaccine was followed by DPT vaccine
June 23rd, 2006
Female mortality is increased by high-titer measles vaccine followed by diphtheria-tetanus-pertussis (DTP) or inactivated polio vaccination. According to recent research from Guinea-Bissau, Sudan, and Canada, "West African studies have hypothesized that increased female mortality after high-titer measles vaccine (HTMV) was due to subsequent diphtheria-tetanus-pertussis (DTP) and inactivated polio vaccine (IPV) vaccinations. We tested two deductions from this hypothesis in HTMV studies from rural Sudan and Kinshasa; first, there should be no excess female mortality for HTMV recipients when DTP was not given after HTMV and second, excess female mortality should only be...
Source: Biotech Law Weekly (2006-06-23)
|
